《苯丙氨酸剥夺通过扰乱内质网稳态抑制多发性骨髓瘤进展》[《中国药理学通报》14 (2024) 3493 - 3512]的勘误
Erratum to "Phenylalanine deprivation inhibits multiple myeloma progression by perturbing endoplasmic reticulum homeostasis" [Acta Pharm Sin B 14 (2024) 3493-3512].
作者信息
Cheng Longhao, Wang Xiaoxue, Liu Aijun, Zhu Ying, Cheng Hu, Yu Jiangling, Gong Lili, Liu Honglin, Shen Guolin, Liu Lihong
机构信息
Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Capital Medical University, Beijing 100029, China.
Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China.
出版信息
Acta Pharm Sin B. 2024 Nov;14(11):5088. doi: 10.1016/j.apsb.2024.08.018. Epub 2024 Aug 26.
Abstract
[This corrects the article DOI: 10.1016/j.apsb.2024.04.021.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.apsb.2024.04.021。]
相似文献
1
Erratum to "Phenylalanine deprivation inhibits multiple myeloma progression by perturbing endoplasmic reticulum homeostasis" [Acta Pharm Sin B 14 (2024) 3493-3512].《苯丙氨酸剥夺通过扰乱内质网稳态抑制多发性骨髓瘤进展》[《中国药理学通报》14 (2024) 3493 - 3512]的勘误
Acta Pharm Sin B. 2024 Nov;14(11):5088. doi: 10.1016/j.apsb.2024.08.018. Epub 2024 Aug 26.
2
Erratum: Author correction to "TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner" [Acta Pharm Sin B 11(12) (2021) 3994-4007].勘误：“TMEM16A以WNK1依赖的方式抑制血管紧张素II诱导的基底动脉平滑肌细胞迁移”[《中国药理学报B》11(12)(2021)3994 - 4007]的作者更正。
Acta Pharm Sin B. 2023 Mar;13(3):1340-1343. doi: 10.1016/j.apsb.2023.01.001. Epub 2023 Feb 2.
3
Erratum: Author correction to "The FAP-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway" [Acta Pharm Sin B 12 (2022) 1288-1304].勘误：作者对《FAP激活的前药Z-GP-DAVLBH通过抑制AXL通路抑制骨肉瘤细胞的生长和肺转移》[《中国药理学通报》12 (2022) 1288 - 1304]一文的更正。
Acta Pharm Sin B. 2023 Mar;13(3):1337-1339. doi: 10.1016/j.apsb.2022.12.020. Epub 2023 Feb 1.
4
Erratum: Author correction to "Generation of Gal-enhanced bifunctional tumor vaccine" [Acta Pharm Sin B 12 (2022) 3177-3186].勘误：“Gal增强型双功能肿瘤疫苗的生成”[《中国药理学通报》12 (2022) 3177 - 3186]的作者更正。
Acta Pharm Sin B. 2025 Feb;15(2):1207. doi: 10.1016/j.apsb.2024.11.021. Epub 2024 Nov 29.
5
Erratum: Author correction to 'Pharmacologically targeting molecular motor promotes mitochondrial fission for anti-cancer' [Acta Pharm Sin B 11 (2021) 1853-1866].勘误：“Pharmacologically targeting molecular motor promotes mitochondrial fission for anti-cancer” [《中国药理学报B》11 (2021) 1853-1866]的作者更正。
Acta Pharm Sin B. 2024 May;14(5):2358. doi: 10.1016/j.apsb.2024.02.013. Epub 2024 Feb 21.
6
Erratum: Author correction to "Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits" [Acta Pharm Sin B 14 (2024) 2732-2747].勘误：《气体驱动纳米马达通过调节肠道免疫环境-血液结合素-微生物群回路缓解结肠炎》[《药学学报B》14 (2024) 2732-2747]的作者更正。
Acta Pharm Sin B. 2024 Sep;14(9):4193. doi: 10.1016/j.apsb.2024.06.005. Epub 2024 Jun 15.
7
Erratum: Author correction to 'Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' [Acta Pharm Sin B 12 (2022) 4458-4471].勘误：“使用六组氨酸金属纳米载体共递送尼日利亚菌素和地西他滨用于焦亡诱导的免疫治疗”[《中国药理学报B》12 (2022) 4458 - 4471]的作者更正。
Acta Pharm Sin B. 2024 May;14(5):2359-2360. doi: 10.1016/j.apsb.2024.02.021. Epub 2024 Feb 29.
8
Erratum: Author correction to "Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning" [Acta Pharm Sin B 12 (2022) 2429-2442].勘误：作者对“通过基于连接图谱的药物重新定位鉴定抗蠕虫药帕苯达唑作为头颈部鳞状细胞癌的治疗分子”[《中国药理学通报》12 (2022) 2429-2442]进行的更正。
Acta Pharm Sin B. 2024 Nov;14(11):5089-5090. doi: 10.1016/j.apsb.2024.09.006. Epub 2024 Sep 10.
9
Erratum: Author correction to "Tumor-microenvironment activated duplex genome-editing nanoprodrug for sensitized near-infrared titania phototherapy" [Acta Pharm Sin B (2022) 4224-4234].勘误：《肿瘤微环境激活的双链基因组编辑纳米前药用于敏化近红外二氧化钛光疗》[《药学学报B》（2022年）4224 - 4234]的作者更正。
Acta Pharm Sin B. 2024 Feb;14(2):897-899. doi: 10.1016/j.apsb.2023.09.002. Epub 2023 Sep 7.
10
Erratum: Author correction to 'Discovery of the radio-protecting effect of ecliptae herba, its constituents and targeting p53-mediated apoptosis and ' [Acta Pharm Sin B 13 (2023) 1216-1230].勘误：《墨旱莲及其成分的辐射防护作用与靶向p53介导的细胞凋亡》的作者更正 [《中国药理学通报》13 (2023) 1216 - 1230] 。
Acta Pharm Sin B. 2023 Jun;13(6):2815-2816. doi: 10.1016/j.apsb.2023.03.026. Epub 2023 Mar 31.
Zotero 插件